EUDA Health Holdings Limited Announces Warrant Agreement Amendment
SINGAPORE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA), a prominent non-invasive healthcare provider operating in Singapore, Malaysia, and China, has announced a significant amendment to its warrant agreement with Streeterville Capital, LLC. This Warrant Amendment is poised to impact the company’s future financing strategy and shareholder value.
Details of the Original Warrant Agreement
On November 26, 2025, EUDA executed a securities purchase agreement with Streeterville Capital, resulting in the issuance of a warrant exercisable into up to 2,000,000 newly issued ordinary shares of EUDA. The aggregate purchase price for these warrants was set at US$100,000. The issuance of these warrants took place on December 4, 2025, following a prospectus supplement as part of a registration statement filed with the Securities and Exchange Commission on October 18, 2024.
The original warrant includes a cash exercise period of ninety (90) days, unless extended, during which Streeterville Capital has the option to exercise the warrant for cash. If not exercised, a “cashless” exercise mechanism is triggered, resulting in EUDA issuing one ordinary share for every ten outstanding warrant shares after a two-week grace period post the cash exercise period.
Key Amendments to the Warrant Agreement
As part of the Warrant Amendment finalized on December 16, 2025, EUDA and Streeterville Capital have implemented important changes:
- The exercise price of the warrant has been reduced from US$6.00 per share to US$4.00 per share.
- The minimum closing price required to trigger a “Forced Exercise” has been lowered from US$7.50 to US$6.00.
All other terms of the warrant agreement remain unchanged, potentially enhancing the attractiveness of the warrant for investors.
About EUDA Health Holdings Limited
EUDA Health Holdings Limited (NASDAQ: EUDA) is at the forefront of providing non-invasive healthcare solutions across Asia, particularly in Singapore, Malaysia, and China. The company is strategically focused on addressing the healthcare needs of over 1.8 billion people within a rapidly aging demographic that is experiencing significant transformations. With more than 30% of the population aging hastily, EUDA aims to evolve the healthcare paradigm from conventional reactive treatment to proactive, longevity-oriented care.
Additionally, EUDA is committed to providing science-backed health solutions that are accessible and innovative, underlining its mission to lead in the proactive healthcare sector. The company also manages property operations in Singapore.
Forward-Looking Statements
This release may include forward-looking statements that reflect EUDA's expectations regarding future events. These statements are identified by terms like “estimates,” “expects,” “anticipates,” and similar expressions. However, these projections are subject to risks and uncertainties, and actual results may differ significantly from those articulated in forward-looking statements.
EUDA does not undertake any obligation to update or revise these statements except as required by law, emphasizing the need for investors to consider caution when relying on such future predictions.
Contact Information
For further inquiries regarding this announcement, please contact:
Christian Arnell
Christensen Advisory
Phone: +852 9040 0621
Email: christian.arnell@christensencomms.com